Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Thomas Pedersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250 Cambridge, MA U.S.A. - Allarity Therapeutics, Inc. , a clinical-stage... | April 22, 2022
Cambridge, MA U.S.A. (April 22, 2022) - Allarity Therapeutics, Inc. (Nasdaq: ALLR) ("Allarity" or the "Company"), a clinical-stage pharmaceutical company developing novel oncology therapeutics together
Listen to our exclusive premiere of Norwegian progressive death metallers Hypermass playing their track "The Degenerate Strain."
A working paper from UC San Diego has come up with a new model for predicting home prices that puts an emphasis on online search activity.